Patient-Reported Outcomes in Head and Neck Cancer

Summary

Weekly electronic reporting of patient-reported outcomes will be tested in a national trial in participants undergoing radiotherapy for head and neck cancer.

The study is a national study under the Danish Head and Neck Cancer Group (DAHANCA) and all 6 centers in Denmark will participate.

The clinical endpoints will be:

* Quality of life
* Objective toxicity score (DAHANCA)
* Opioid treatment
* Tube feeding
* Weight loss
* Hospitalization
* Compliance to treatment

Conditions

• Head and Neck Cancer
• Radiotherapy Side Effect

Interventions

OTHER

Electronic Patient-Reported Outcome

Weekly reporting of patient-reported outcomes on a tablet for closer contact between patient and clinic during radiotherapy.

Sponsors & Collaborators

• Danish Comprehensive Cancer Center

  collaborator OTHER

• Danish Cancer Society

  collaborator OTHER

• University of Copenhagen

  collaborator OTHER

• Danish Head and Neck Cancer Group

  collaborator NETWORK

• Herlev Hospital

  collaborator OTHER

• Zealand University Hospital

  collaborator OTHER

• Odense University Hospital

  collaborator OTHER

• Aalborg University Hospital

  collaborator OTHER

• Aarhus University Hospital

  collaborator OTHER

• Rigshospitalet, Denmark

  lead OTHER

Principal Investigators

• Cecilie Holländer-Mieirtz, MD · Rigshospitalet, Denmark

Study Design

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

SEQUENTIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-06-13

Primary Completion

2024-03-01

Completion

2024-08-01

Countries

• Denmark

Study Locations